2007, Volume 14, Supplement 3: Optimising global risk reduction: insights from REACH

September 2007 Br J Cardiol 2007;14(Suppl 3):S2-S16

Optimising global risk reduction: insights from REACH


This supplement is based on the proceedings of a one-day round table meeting held at the National Heart and Lung Institute, London, in June 2007 to discuss findings of the Reduction of Atherothrombosis for Continued Health (REACH) Registry. This international contemporary registry is looking at the association between multiple symptomatic locations of atherothrombosis (i.e. multi-vascular disease) and cardiovascular event rates, considering the characteristics and outcomes of stable patients in a community setting for whom one-year follow-up data were available. The registry is an ongoing study and the wide implications of this study for UK physicians across various different disciplines were discussed. ...

| View